SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-058197
Filing Date
2020-05-07
Accepted
2020-05-07 17:24:46
Documents
7
Period of Report
2020-03-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2014909-1_8k.htm 8-K/A 22680
2 EXHIBIT 23.1 tm2014909d1_ex23-1.htm EX-23.1 4020
3 EXHIBIT 99.1 tm2014909d1_ex99-1.htm EX-99.1 712300
4 EXHIBIT 99.2 tm2014909d1_ex99-2.htm EX-99.2 174546
5 GRAPHIC tm2014909d1_ex99-1img01.jpg GRAPHIC 5856
6 GRAPHIC tm2014909d1_ex23-1img001.jpg GRAPHIC 3941
7 GRAPHIC tm2014909d1_ex99-1img02.jpg GRAPHIC 5580
  Complete submission text file 0001104659-20-058197.txt   936480
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38356 | Film No.: 20857740
SIC: 2834 Pharmaceutical Preparations